Shijun Yan

Scientist II, In Vivo Biology at BioAge Labs
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Richmond, California, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Scientist II, In Vivo Biology
      • Mar 2023 - Present

      Richmond, California, United States

    • Scientist, In Vivo Biology
      • Mar 2022 - Mar 2023

      Richmond, California, United States

    • Research Services
    • 700 & Above Employee
    • Research Associate
      • Mar 2017 - Mar 2022

      Indianapolis, Indiana Area Identifying new therapeutic targets in metabolism diseases including diabetes and obesity. Investigating the role of gut G protein-coupled receptors (GPCRs) on food intake and glucose homeostasis, and the effect of gut GPCR on incretin secretion and signaling.

    • United States
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Researcher
      • Jul 2013 - Aug 2016

      Lawrence, Kansas Area Lead a project investigating the pathology of mitochondrial target and its contribution to neurotransmission and synaptic deficits in diabetes, aging and age-related neurodegenerative disease.-Diabetes (2016), Scientific Report (2016).

    • United States
    • Higher Education
    • 700 & Above Employee
    • Visiting Researcher
      • Sep 2011 - May 2013

      New York, New York, United States Identified the anti-Alzheimer’s Disease (AD) effects of two natural compounds: Notoginsenoside R1 and Geniposide.-Scientific Report (2014), Neuropharmacology (2015).

    • China
    • Higher Education
    • 500 - 600 Employee
    • Graduate Student Researcher
      • Sep 2008 - Jul 2011

      Beijing, China Established a high throughput screening method for discovery of potential Methylglyoxal (MG) trapping reagents using HPLC approach. Identified that (+)-Catechin, one of catechins present largely in tea, exhibits strong effect of MG-trapping, which might be a potential drug candidate for the supplementary treatment of diabetic complication. -JAFC (2012), Mol Nutr Food Res (2014).

Education

  • Columbia University in the City of New York
    Doctor of Philosophy (Ph.D.), Joint Doctoral's Training Program
    2011 - 2013
  • Beijing Normal University
    Doctor of Philosophy (Ph.D.), Neuropharmacology
    2008 - 2013
  • Beijing Normal University
    Bachelor's degree, Biotechnology
    2004 - 2008

Community

You need to have a working account to view this content. Click here to join now